Stapgen LLC

Stapgen LLC

We aim to prevent T2DM prior to the rise of blood sugar. We have the patent.

Claim My Business
Security Type
Financial Services, Healthcare & Medical, Community & Lifestyle, Education
Min Investment
Reading, MA
Expected Close Date
April 30, 2023
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Key Deal Facts

Patented STAP-Test may detect and provide risk of developing Type 2 Diabetes 5 years in advance
Few other companies in USA can detect and intercept developing T2DM prior to the rise of blood sugar
We believe Stapgen is the only company licensed for the device world-wide
Dr. MS Malo dedicated over 40 years in the field of Medicine and Biotech and have 7 patents
6.7 million death attributed to diabetes world-wide in 2021 according to IDF
Stapgen's mission is to save about 80% of those untimely, and unwanted death

Management Team / Advisory Board Bios

Biplab Malo Founder & CEOGraduated from UPENN, School of Dental Medicine in 2000; 20 years experience in business. I have exclusive license for STAP-test for detecting, and treating the incipient diabetes. Dr. MS Malo is the owner of the patent., Madhu S. Malo, MBBS, PhD Chief Scientist Discovered the Cause of Type 2 diabetes. Invented the STAP-test. Former assistant professor of Harvard Medical School, Postdoc of MIT, PhD from Sidney University.
Amount Raised : $71,711
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter